Vaccine Delivery Methods into the Future - Wikidata - wikimedia - TriplyDB

Vaccine Delivery Methods into the Future

Vaccine Delivery Methods into the Future

http://www.wikidata.org/entity/Q42434139

about

Replicon RNA Viral Vectors as Vaccines Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses.Mannosylated T/Tn with Freund's adjuvant induces cellular immunity.

P2860

Q28076639-A3D5A705-B7EB-4C4F-BB4C-E90C5BA26ED0 Q38737582-BD559F27-B1B4-44A9-A509-1634F1B43366 Q48566108-07B50AE6-CC65-45C6-A5EB-ACFE8CE5C589

P2860

Vaccine Delivery Methods into the Future

http://www.wikidata.org/entity/Q42434139

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Vaccine Delivery Methods into the Future

@en

Vaccine Delivery Methods into the Future

@nl

type

label

Vaccine Delivery Methods into the Future

@en

Vaccine Delivery Methods into the Future

@nl

prefLabel

Vaccine Delivery Methods into the Future

@en

Vaccine Delivery Methods into the Future

@nl

P1433

Q42434139-407C5BE5-9833-4A82-ACA1-3DEA825AA994

P1476

Q42434139-1CA29EC4-5A5B-441F-8CC0-1689EDA215E5

P2860

Q42434139-074B7359-979B-45C9-86E8-CC65F8D7B313

Q42434139-0BA724A0-A7D3-4D7B-B7D8-4EDC82DBD558

Q42434139-1611A720-3B48-4857-AEAE-A3142EDE775F

Q42434139-188F28DE-1AC8-4A4E-A40C-AF53C4C817D6

Q42434139-1A2127A9-7D81-468D-8953-5D0CE1AC3ABA

Q42434139-227BDD70-7C10-4409-82D9-13D309E28DE6

Q42434139-22FEA42F-BC7F-45B5-B9DF-3244C42ADD8D

Q42434139-3C7272DC-EFF9-41C7-86AC-9765C1FA95CA

Q42434139-3DF10A02-3FE5-4581-A148-474000E18722

Q42434139-496F36B0-13F6-4381-8230-4254A760DD8A

P31

Q42434139-67205BD4-DFD7-4351-B2E8-3656B70B1D44

Q42434139-6d3e7ae5-59c9-458d-aec8-312c8179b73c

P356

Q42434139-1C54B1CB-3666-4430-93D0-FFE1EC79100E

P433

Q42434139-7A29D7E7-4FC5-409D-A69E-8A0A02F6914F

P478

Q42434139-31B38EDA-0783-45E0-AF3D-0A997393EFC5

P50

Q42434139-EA9EA65B-F18B-49DE-B0F3-168620F31C36

P577

Q42434139-70437FE6-35D7-4082-B7A5-C93B1B923629

P5875

Q42434139-830CB4EF-253C-49A0-A376-B9E7F8A23C58

P698

Q42434139-91D700F9-B4C7-4474-ADF9-54071E472E5F

P932

Q42434139-4EE961D1-DEB0-4BE8-9D26-32023D791FF0

P356

VACCINES4020009

P1433

P1476

Vaccine Delivery Methods into the Future

@en

P2860

Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators

The Use of Synthetic Carriers in Malaria Vaccine Design

Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity

Gavi HPV Programs: Application to Implementation

Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design

Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery

Branched peptides as therapeutics.

Dendritic cell immunotherapy: clinical outcomes

DNA vaccines: ready for prime time?

Clinical applications of DNA vaccines: current progress.

P31

scholarly article

P356

10.3390/VACCINES4020009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Vasso Apostolopoulos

P577

2016-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

299498648

http://www.w3.org/2001/XMLSchema#string

P698

27043641

http://www.w3.org/2001/XMLSchema#string

P932

4931626

http://www.w3.org/2001/XMLSchema#string